5 completed. 5 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 5 | Completed 5 |
Follow Upper Respiratory Tract Infection: new trials by email Literature Review of Upper Respiratory Tract Infection trials Research Report on Upper Respiratory Tract Infection
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Efficacy of the 2023-2024 Updated COVID-19 Vaccines Against COVID-19 Infection Novavax COVID-19 vaccine (2023-2024 formula XBB containing), Pfizer COVID-19 mRNA vaccine (2023-2024 formula XBB containing) - COVID-19, Vaccine-Preventable Diseases | Phase 4 | Completed | Sarang K. Yoon, DO, MOH | 1188 | 2023-11-22 | 2026-01-28 |
| Bioequivalence Study of Azithromycin Capsule and Reference Formulation Sumamed * in Healthy Adult Subjects in China test product (T) azithromycin capsule and reference product (R) azithromycin capsule "Sumamed®" - Upper Respiratory Tract Infection, Lower Respiratory Infection | Phase 4 | Completed | Peking University People's Hospital | 48 | 2022-11-16 | 2023-11-28 |
| Comparison of Efficacy and Tolerability of Two Cough Syrups in Cough Due to Cold in Children. protective cough syrup, carbocisteine cough syrup - Cough, Upper Respiratory Tract Infection | Phase 4 | Completed | Clalit Health Services | 150 | 2013-12-01 | 2018-02-23 |
| Using Pneumococcal Vaccines in Combination for Maximum Protection From Ear and Lung Infections in First 3 Years of Life Prevenar13, Synflorix - Otitis Media, Febrile Illness | Phase 4 | Completed | Menzies School of Health Research | 261 | 2013-03-12 | 2020-03-25 |
| Reducing the Acute Care Burden of Childhood Asthma on Health Services in British Columbia Arm 1 Oral Cortico Steroids - Upper Respiratory Tract Infection, Asthma | Phase 4 | Completed | University of British Columbia | 92 | 2011-04-01 | 2021-05-14 |
Respiratory Tract Infections (5) · Cough (2) · Asthma (1) · COVID-19 (1) · Cellulitis (1) · Common Cold (1) · Otitis Media (1) · Respiration Disorders (1) · Vaccine-Preventable Diseases (1)
Infections (5) · Respiratory Tract Diseases (5) · Pathological Conditions, Signs and Symptoms (3) · Lung Diseases (2) · RNA Virus Infections (2) · Respiration Disorders (2) · Signs and Symptoms (2) · Signs and Symptoms, Respiratory (2) · Virus Diseases (2) · Bronchial Diseases (1) · Connective Tissue Diseases (1) · Coronaviridae Infections (1) · Coronavirus Infections (1) · Ear Diseases (1) · Hypersensitivity (1)
13-valent pneumococcal vaccine (1) · Azithromycin (1) · NVX-CoV2373 adjuvated lipid nanoparticle (1) · PHiD-CV vaccine (1) · Prednisone (1)
Clalit Health Services (1) · Menzies School of Health Research (1) · Peking University People's Hospital (1) · Sarang K. Yoon, DO, MOH (1) · University of British Columbia (1)
Australia (1) · Canada (1) · China (1) · Israel (1) · United States (1)
Amanda J Leach, PhD (1) · Bruce Carleton, B.Pharm, Pharm.D. (1) · Herman Avner Cohen, Professor (1) · Sarang K Yoon, DO (1)
PMID 32448790, PMID 35772449, PMID 38829821, PMID 41592795, PMID 42811742